Skip to main content
SpringerLink
Log in

Nausea and Vomiting Related to the Central Nervous System Diseases

  • Chapter
  • First Online:
Nausea and Vomiting

Abstract

Nausea and vomiting could result from various central nervous system causes such as migraine, seizures, stroke, infections such as tumor, tumors (primary or metastatic), pseudotumor cerebri, etc. However, our knowledge about the prevalence of nausea and vomiting in various primary central nervous system diseases and their underlying pathophysiology is limited. Similarly, there is paucity of data on improvement in symptoms of nausea and emesis in response to disease-specific treatment of underlying central nervous system disease process. Improved understanding of the pathophysiologic basis of these symptoms in central nervous system diseases has important implications for the exploitation of novel mechanisms or the development of novel therapies for the relief of nausea and emesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Quigley EM, Hasler WL, Parkman HP. AGA technical review on nausea and vomiting. Gastroenterology. 2001;120(1):263–86.

    Article  CAS  PubMed  Google Scholar 

  2. Hasler WL, Chey WD. Nausea and vomiting. Gastroenterology. 2003;125(6):1860–7.

    Article  PubMed  Google Scholar 

  3. Lipton RB, Buse DC, Saiers J, Serrano D, Reed ML. Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. J Med Econ. 2013;16(4):490–9.

    Article  PubMed  Google Scholar 

  4. Stern RM. The psychophysiology of nausea. Acta Biol Hung. 2002;53(4):589–99.

    Article  CAS  PubMed  Google Scholar 

  5. Horn CC. Why is the neurobiology of nausea and vomiting so important? Appetite. 2008;50(2–3):430–4.

    Article  PubMed  Google Scholar 

  6. Horn CC. Measuring the nausea-to-emesis continuum in non-human animals: refocusing on gastrointestinal vagal signaling. Exp Brain Res. 2014;232(8):2471–81.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Kowalski A, Rapps N, Enck P. Functional cortical imaging of nausea and vomiting: a possible approach. Auton Neuroscience: basic & clinical. 2006;129(1–2):28–35.

    Google Scholar 

  8. Napadow V, Sheehan JD, Kim J, Lacount LT, Park K, Kaptchuk TJ, et al. The brain circuitry underlying the temporal evolution of nausea in humans. Cereb Cortex (New York, NY: 1991). 2013;23(4):806–13.

    Google Scholar 

  9. Sclocco R, Kim J, Garcia RG, Sheehan JD, Beissner F, Bianchi AM, et al. Brain Circuitry Supporting Multi-Organ Autonomic Outflow in Response to Nausea. Cereb Cortex (New York, NY: 1991). 2016;26:485–97.

    Google Scholar 

  10. Hornby PJ. Central neurocircuitry associated with emesis. Am J Med. 2001;111 Suppl 8A:106s–12s.

    Google Scholar 

  11. Miller AD. Central mechanisms of vomiting. Dig. Dis. Sci. 1999;44 Suppl 8:39s–43s.

    Google Scholar 

  12. Kim J, Napadow V, Kuo B, Barbieri R. A combined HRV-fMRI approach to assess cortical control of cardiovagal modulation by motion sickness. Conf Proc IEEE Eng Med Biol Soc. 2011:2825–8.

    Google Scholar 

  13. Borsook D, Sava S, Becerra L. The pain imaging revolution: advancing pain into the 21st century. Neuroscientist Rev J Bringing Neurobiol Neurol Psychiatry. 2010;16(2):171–85.

    Google Scholar 

  14. Doan L, Manders T, Wang J. Neuroplasticity underlying the comorbidity of pain and depression. Neural Plast. 2015;2015:504691.

    PubMed  PubMed Central  Google Scholar 

  15. Pryse-Phillips W, Aube M, Bailey P, Becker WJ, Bellavance A, Gawel M, et al. A clinical study of migraine evolution. Headache. 2006;46(10):1480–6.

    Article  PubMed  Google Scholar 

  16. Lipton RB, Buse DC, Saiers J, Fanning KM, Serrano D, Reed ML. Frequency and burden of headache-related nausea: results from the American Migraine Prevalence and Prevention (AMPP) study. Headache. 2013;53(1):93–103.

    Article  PubMed  Google Scholar 

  17. Reed ML, Fanning KM, Serrano D, Buse DC, Lipton RB. Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results. Headache. 2015;55(1):76–87.

    Article  PubMed  Google Scholar 

  18. Maniyar FH, Sprenger T, Schankin C, Goadsby PJ. The origin of nausea in migraine-a PET study. J Headache Pain. 2014;15:84.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Maniyar FH, Sprenger T, Monteith T, Schankin CJ, Goadsby PJ. The premonitory phase of migraine—what can we learn from it? Headache. 2015;55(5):609–20.

    Article  PubMed  Google Scholar 

  20. Pierce M. Oral triptans and nausea: treatment considerations in migraine. Headache. 2013;53 Suppl 1:17–20.

    Article  PubMed  Google Scholar 

  21. Lainez MJ, Garcia-Casado A, Gascon F. Optimal management of severe nausea and vomiting in migraine: improving patient outcomes. Patient Relat Outcome Meas. 2013;4:61–73.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Silberstein SD, Young WB, Mendizabal JE, Rothrock JF, Alam AS. Acute migraine treatment with droperidol: A randomized, double-blind, placebo-controlled trial. Neurology. 2003;60(2):315–21.

    Article  CAS  PubMed  Google Scholar 

  23. Bigal ME, Bordini CA, Speciali JG. Intravenous chlorpromazine in the emergency department treatment of migraines: a randomized controlled trial. J Emerg Med. 2002;23(2):141–8.

    Article  PubMed  Google Scholar 

  24. Kelley NE, Tepper DE. Rescue therapy for acute migraine, part 2: neuroleptics, antihistamines, and others. Headache. 2012;52(2):292–306.

    Article  PubMed  Google Scholar 

  25. Colman I, Brown MD, Innes GD, Grafstein E, Roberts TE, Rowe BH. Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ (Clinical Res Ed). 2004;329(7479):1369–73.

    Google Scholar 

  26. Siddiqui MF, Rast S, Lynn MJ, Auchus AP, Pfeiffer RF. Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey. Parkinsonism Relat Disord. 2002;8(4):277–84.

    Article  CAS  PubMed  Google Scholar 

  27. Goetze O, Wieczorek J, Mueller T, Przuntek H, Schmidt WE, Woitalla D. Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13C-sodium octanoate breath test. Neurosci Lett. 2005;375(3):170–3.

    Article  CAS  PubMed  Google Scholar 

  28. Krygowska-Wajs A, Cheshire Jr WP, Wszolek ZK, Hubalewska-Dydejczyk A, Jasinska-Myga B, Farrer MJ, et al. Evaluation of gastric emptying in familial and sporadic Parkinson disease. Parkinsonism Relat Disord. 2009;15(9):692–6.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Tanaka Y, Kato T, Nishida H, Yamada M, Koumura A, Sakurai T, et al. Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson's disease? An analysis using the 13C-acetate breath test. J Neurol. 2011;258(3):421–6.

    Article  PubMed  Google Scholar 

  30. Heetun ZS, Quigley EM. Gastroparesis and Parkinson's disease: a systematic review. Parkinsonism Relat Disord. 2012;18(5):433–40.

    Article  PubMed  Google Scholar 

  31. Djaldetti R, Baron J, Ziv I, Melamed E. Gastric emptying in Parkinson's disease: patients with and without response fluctuations. Neurology. 1996;46(4):1051–4.

    Article  CAS  PubMed  Google Scholar 

  32. Hardoff R, Sula M, Tamir A, Soil A, Front A, Badarna S, et al. Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov Disord Off J Movement Disord Soc. 2001;16(6):1041–7.

    Google Scholar 

  33. Kurlan R, Nutt JG, Woodward WR, Rothfield K, Lichter D, Miller C, et al. Duodenal and gastric delivery of levodopa in parkinsonism. Ann Neurol. 1988;23(6):589–95.

    Article  CAS  PubMed  Google Scholar 

  34. Kurlan R, Rothfield KP, Woodward WR, Nutt JG, Miller C, Lichter D, et al. Erratic gastric emptying of levodopa may cause “random” fluctuations of parkinsonian mobility. Neurology. 1988;38(3):419–21.

    Article  CAS  PubMed  Google Scholar 

  35. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol. 2003;2(2):107–16.

    Article  PubMed  Google Scholar 

  36. Lu CL, Shan DE, Chen CY, Luo JC, Chang FY, Lee SD, et al. Impaired gastric myoelectrical activity in patients with Parkinson’s disease and effect of levodopa treatment. Dig Dis Sci. 2004;49(5):744–9.

    Article  CAS  PubMed  Google Scholar 

  37. Chen CL, Lin HH, Chen SY, Lin SZ. Utility of electrogastrography in differentiating Parkinson’s disease with or without gastrointestinal symptoms: a prospective controlled study. Digestion. 2005;71(3):187–91.

    Article  PubMed  Google Scholar 

  38. Naftali T, Gadoth N, Huberman M, Novis B. Electrogastrography in patients with Parkinson’s disease. Can J Neurol Sci Le journal canadien des sciences neurologiques. 2005;32(1):82–6.

    Google Scholar 

  39. Connolly BS, Lang AE. Pharmacological treatment of Parkinson disease: a review. JAMA. 2014;311(16):1670–83.

    Article  PubMed  Google Scholar 

  40. Perez-Lloret S, Rascol O. Dopamine receptor agonists for the treatment of early or advanced Parkinson’s disease. CNS Drugs. 2010;24(11):941–68.

    Article  CAS  PubMed  Google Scholar 

  41. Markham C, Diamond SG, Treciokas LJ. Carbidopa in Parkinson disease and in nausea and vomiting of levodopa. Arch Neurol. 1974;31(2):128–33.

    Article  CAS  PubMed  Google Scholar 

  42. Braun M, Cawello W, Boekens H, Horstmann R. Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotine. Br J Clin Pharmacol. 2009;67(2):209–15.

    Article  CAS  PubMed  Google Scholar 

  43. Parkes JD. Domperidone and Parkinson’s disease. Clin Neuropharmacol. 1986;9(6):517–32.

    Article  CAS  PubMed  Google Scholar 

  44. Hauser RA, Isaacson S, Clinch T. Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection. Parkinsonism Relat Disord. 2014;20(11):1171–6.

    Article  PubMed  Google Scholar 

  45. Shigematsu K, Shimamura O, Nakano H, Watanabe Y, Sekimoto T, Shimizu K, et al. Vomiting should be a prompt predictor of stroke outcome. Emerg Med J. 2013;30(9):728–31.

    Article  PubMed  Google Scholar 

  46. Runchey S, McGee S. Does this patient have a hemorrhagic stroke?: clinical findings distinguishing hemorrhagic stroke from ischemic stroke. JAMA. 2010;303(22):2280–6.

    Article  CAS  PubMed  Google Scholar 

  47. Lee KL, Shin JI. Cyclic vomiting syndrome developed after stroke. Ann Rehabil Med. 2012;36(1):141–3.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Searls DE, Pazdera L, Korbel E, Vysata O, Caplan LR. Symptoms and signs of posterior circulation ischemia in the new England medical center posterior circulation registry. Arch Neurol. 2012;69(3):346–51.

    Article  PubMed  Google Scholar 

  49. Emsley HC. Posterior circulation stroke: still a Cinderella disease. BMJ (Clin Res Ed). 2013;346:f3552.

    Google Scholar 

  50. Krieger DW, Demchuk AM, Kasner SE, Jauss M, Hantson L. Early clinical and radiological predictors of fatal brain swelling in ischemic stroke. Stroke J Cerebral Circu. 1999;30(2):287–92.

    Google Scholar 

  51. Oostenbrink R, Moons KG, Donders AR, Grobbee DE, Moll HA. Prediction of bacterial meningitis in children with meningeal signs: reduction of lumbar punctures. Acta Paediatr (Oslo, Norway: 1992). 2001;90(6):611–7.

    Google Scholar 

  52. Takahashi T, Miyazawa I, Misu T, Takano R, Nakashima I, Fujihara K, et al. Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations. J Neurol Neurosurg Psychiatry. 2008;79(9):1075–8.

    Article  CAS  PubMed  Google Scholar 

  53. Apiwattanakul M, Popescu BF, Matiello M, Weinshenker BG, Lucchinetti CF, Lennon VA, et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol. 2010;68(5):757–61.

    Article  PubMed  Google Scholar 

  54. Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–89.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Iorio R, Lucchinetti CF, Lennon VA, Farrugia G, Pasricha PJ, Weinshenker BG, et al. Intractable nausea and vomiting from autoantibodies against a brain water channel. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2013;11(3):240–5.

    Google Scholar 

  56. Popescu BF, Lennon VA, Parisi JE, Howe CL, Weigand SD, Cabrera-Gomez JA, et al. Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology. 2011;76(14):1229–37.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet (London, England). 2004;364(9451):2106–12.

    Google Scholar 

  58. Pittock SJ, Lucchinetti CF. Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later. Ann N Y Acad Sci. 2015.

    Google Scholar 

  59. Duvernoy HM, Risold PY. The circumventricular organs: an atlas of comparative anatomy and vascularization. Brain Res Rev. 2007;56(1):119–47.

    Article  PubMed  Google Scholar 

  60. Gross PM. Morphology and physiology of capillary systems in subregions of the subfornical organ and area postrema. Can J Physiol Pharmacol. 1991;69(7):1010–25.

    Article  CAS  PubMed  Google Scholar 

  61. Bronstein AM. Visually induced paroxysmal nausea and vomiting as presenting manifestations of multiple sclerosis. J Neurol Neurosurg Psychiatry. 1996;60(6):703.

    Google Scholar 

  62. Szilagyi A, Schipper HM, Just N. Nausea, vomiting and diarrhea: an unusual presentation of multiple sclerosis. Can J Gastroenterol Journal canadien de gastroenterologie. 1997;11(4):367–70.

    Google Scholar 

  63. Gupta M, Davis M, LeGrand S, Walsh D, Lagman R. Nausea and vomiting in advanced cancer: the Cleveland Clinic protocol. J Support Oncol. 2013;11(1):8–13.

    PubMed  Google Scholar 

  64. Lin X, DeAngelis LM. Treatment of brain metastases. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33(30):3475–84.

    Google Scholar 

  65. Baker PC, Bernat JL. The neuroanatomy of vomiting in man: association of projectile vomiting with a solitary metastasis in the lateral tegmentum of the pons and the middle cerebellar peduncle. J Neurol Neurosurg Psychiatry. 1985;48(11):1165–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Bhangoo SS, Linskey ME, Kalkanis SN. Evidence-based guidelines for the management of brain metastases. Neurosurg Clin N Am. 2011;22(1):97–104, viii.

    Article  PubMed  Google Scholar 

  67. Lo SS, Gore EM, Bradley JD, Buatti JM, Germano I, Ghafoori AP, et al. ACR Appropriateness Criteria(R) pre-irradiation evaluation and management of brain metastases. J Palliat Med. 2014;17(8):880–6.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Yushak ML, Chiang VL, Kluger HM. Clinical trials in melanoma patients with brain metastases. Pigment Cell Melanoma Res. 2015;28(6):741–3.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Shuper A, Goldberg-Stern H. Ictus emeticus (ictal vomiting). Pediatr Neurol. 2004;31(4):283–6.

    Article  PubMed  Google Scholar 

  70. Panayiotopoulos CP. Vomiting as an ictal manifestation of epileptic seizures and syndromes. J Neurol Neurosurg Psychiatry. 1988;51(11):1448–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Caraballo R, Cersosimo R, Medina C, Fejerman N. Panayiotopoulos-type benign childhood occipital epilepsy: a prospective study. Neurology. 2000;55(8):1096–100.

    Article  CAS  PubMed  Google Scholar 

  72. Kivity S, Ephraim T, Weitz R, Tamir A. Childhood epilepsy with occipital paroxysms: clinical variants in 134 patients. Epilepsia. 2000;41(12):1522–33.

    Article  CAS  PubMed  Google Scholar 

  73. Lada C, Skiadas K, Theodorou V, Loli N, Covanis A. A study of 43 patients with panayiotopoulos syndrome, a common and benign childhood seizure susceptibility. Epilepsia. 2003;44(1):81–8.

    Article  PubMed  Google Scholar 

  74. Mellish LC, Dunkley C, Ferrie CD, Pal DK. Antiepileptic drug treatment of rolandic epilepsy and Panayiotopoulos syndrome: clinical practice survey and clinical trial feasibility. Arch Dis Child. 2015;100(1):62–7.

    Article  PubMed  Google Scholar 

  75. Chen C, Yen DJ, Yiu CH, Shih YH, Yu HY, Su MS. Ictal vomiting in partial seizures of temporal lobe origin. Eur Neurol. 1999;42(4):235–9.

    Article  CAS  PubMed  Google Scholar 

  76. Devinsky O, Frasca J, Pacia SV, Luciano DJ, Paraiso J, Doyle W. Ictus emeticus: further evidence of nondominant temporal involvement. Neurology. 1995;45(6):1158–60.

    Article  CAS  PubMed  Google Scholar 

  77. Kramer RE, Luders H, Goldstick LP, Dinner DS, Morris HH, Lesser RP, et al. Ictus emeticus: an electroclinical analysis. Neurology. 1988;38(7):1048–52.

    Article  CAS  PubMed  Google Scholar 

  78. Schauble B, Britton JW, Mullan BP, Watson J, Sharbrough FW, Marsh WR. Ictal vomiting in association with left temporal lobe seizures in a left hemisphere language-dominant patient. Epilepsia. 2002;43(11):1432–5.

    Article  PubMed  Google Scholar 

  79. Catenoix H, Isnard J, Guenot M, Petit J, Remy C, Mauguiere F. The role of the anterior insular cortex in ictal vomiting: a stereotactic electroencephalography study. Epilepsy Behav. 2008;13(3):560–3.

    Article  PubMed  Google Scholar 

  80. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159–65.

    Article  PubMed  Google Scholar 

  81. Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology. 1991;41(2 (Pt 1)):239–44.

    Google Scholar 

  82. Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia Int J Headache. 1990;10(6):331–5.

    Google Scholar 

  83. Kapoor KG. Etiology of dizziness, tinnitus, and nausea in idiopathic intracranial hypertension. Med Hypotheses. 2008;71(2):310–1.

    Article  PubMed  Google Scholar 

  84. Wakerley BR, Tan MH, Ting EY. Idiopathic intracranial hypertension. Cephalalgia Int J Headache. 2015;35(3):248–61.

    Google Scholar 

  85. Schmal F. Neuronal mechanisms and the treatment of motion sickness. Pharmacology. 2013;91(3–4):229–41.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA

    Braden Kuo MD & Prashant Singh MD

Authors
  1. Braden Kuo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prashant Singh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Braden Kuo MD .

Editor information

Editors and Affiliations

  1. Section on Gastroenterology, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA

    Kenneth L. Koch

  2. Division of Gastroenterology, University of Michigan Health System, Ann Arbor, Michigan, USA

    William L. Hasler

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kuo, B., Singh, P. (2017). Nausea and Vomiting Related to the Central Nervous System Diseases. In: Koch, K., Hasler, W. (eds) Nausea and Vomiting. Springer, Cham. https://doi.org/10.1007/978-3-319-34076-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-34076-0_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-34074-6

  • Online ISBN: 978-3-319-34076-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation